Evidence map›Paper›PMID 31576011›Full record

ArticleOncogene2019

Correction: MUC1-C represses the RASSF1A tumor suppressor in human carcinoma cells.

Hasan Rajabi, Tsuyoshi Hata, Wei Li, Mark D Long, Qiang Hu, Song Liu, Deepak Raina, Ling Kui, Yota Yasumizu, Deli Hong and 2 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncogene, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. The Diagnostic Potential ofFrontiers in oncology · 2022
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Hasan RajabiDana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Tsuyoshi HataDana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Wei LiDana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Mark D LongDepartment of Biostatistics & Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.ORCID http://orcid.org/0000-0003-1120-8176
Qiang HuDepartment of Biostatistics & Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.ORCID http://orcid.org/0000-0002-4090-5539
Song LiuDepartment of Biostatistics & Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Deepak RainaDana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Ling KuiDana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Yota YasumizuDana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Deli HongDana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Mehmet SamurDana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Donald KufeDana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. donald_kufe@dfci.harvard.edu.ORCID http://orcid.org/0000-0001-5743-8888

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiers

PMID31576011
PMCPMC8075859

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.